Research & Development: Page 39

  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Smart Medtech: The Smart Healthcare Environment

    Progress in technology, coupled with medical and scientific advances, is expected to significantly change the healthcare environment. Technology companies, healthcare companies, medical device companies, and others are capitalizing on emerging technologies to provide novel healthcare solutions us...

    By Denise Myshko • Nov. 15, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    New Entrants: The Healthcare Disrupters

    The traditional boundaries between industries and areas of specialization continue to blur. Some of this is being driven by the rise of the Internet of Things and the Internet of Medical Things, as dozens of companies such as Apple, DuPont, General Electric, Google, IBM, and Samsung are shaking u...

    By Denise Myshko • Nov. 15, 2015
  • clinical trial diversity Explore the Trendline➔
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Clinical trial diversity

    As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.

    By PharmaVoice staff
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    Crowdsourcing is a social phenomenon that is providing a platform for everything from funding small businesses to compiling data for research and development of pharmaceuticals and medical devices. Imagine the possibilities of being able to solve and predict disease challenges through the collect...

    By Taren Grom • Oct. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Pharma Trax

    Payer Pressures, Market Access Weigh Upon Life-Sciences Strategy  Trending Now: Biotech, pharma, medical device managers find payer pressures and utilization limits sway commercialization approach. Drug makers and medical device companies are finding their biggest commercial challenges coming fro...

    By PharmaVoice Team • Oct. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Tools of the Trade

    FusionOps Launches Supply Chain Analytics Trending Now:  Cloud solution provides supply chain visibility to help pharma companies drive growth and reduce cost. FusionOps has launched FusionOps Pharma, a new analytics suite designed specifically for the pharmaceutical industry. The new cloud solut...

    By PharmaVoice Team • Oct. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    R&D Moves Slowly Toward Open Source

    Open access and crowdsourcing scientific information to accelerate research and development requires a new way of thinking about how clinical research is conducted and breaking down competitive barriers for the greater good. Crowdsourcing is the process of getting work or funding, usually online,...

    By Denise Myshko • Oct. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Beyond Medical Marijuana

    The broad reaching war on drugs that began more than 40 years ago had an unintended consequence: research on the therapeutic value of controlled substances such marijuana, psychedelics, narcotics, and stimulants stalled. Controlled substances were difficult for researchers to get and research was...

    By Denise Myshko • Oct. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Innovator's Corner

    A New Way to Address Drug-Resistant Infections Magnus Precht, CEO and Co-founder of SinSa Labs, talks about his company’s work to develop a new class of antibiotics engineered to avert antibiotic resistance. Experts say in the future, the crisis in antibiotic resistance will be in E. coli, Klebsi...

    By Magnus Precht of SinSa Labs • Sept. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Network

    Social Media Plays Crucial Role In Patient Recruitment For Diabetes Clinical Trial Trending Now: Social media improves clinical study operations. Dr. Frank Waldron-Lynch from the University of Cambridge implemented a research study to analyze the performance of three recruitment sources and the e...

    By PharmaVoice Team • Sept. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Pharma Trax

    Understanding of Therapeutic Value of Cancer Drugs Increases after Initial Approval Trending now: Ongoing research and real-world application post-approval often reveal greater benefit of cancer therapies. The full therapeutic value of a cancer therapy is typically realized long after the drug’s ...

    By PharmaVoice Team • Sept. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Tools of the Trade

    First Medidata-Sponsored Clinical Trial Assesses Capability of mHealth Tools Trending Now: New study explores potential for providing patients with mobile health tools in a clinical trial setting. Medidata, a leading global provider of cloud-based solutions for clinical research in life sciences,...

    By PharmaVoice Team • Sept. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Calendar

    Coming Attractions The Healthcare Businesswomen’s Association’s (HBA) Annual Conference — Influence and Impact: Imagine the Possibilities — will take place November 3-5, 2015, at the Marriott Marquis in Atlanta. More than 1,200 executives — women and men — will convene to engage in meaningful dia...

    By PharmaVoice Team • Sept. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Biotech Pool Dr. Nathalie Adda Enanta Names Chief Medical Officer Enanta Pharmaceuticals, a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, has appointed Nathalie Adda, M.D., as senior VP and chief medical ...

    By PharmaVoice Team • Sept. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    A Unique Approach to Regenerative Medicine Karine Kleinhaus, M.D., Divisional VP, North America, Pluristem Therapeutics, discusses how the emerging wave of  regenerative and cell therapies could potentially improve the longevity and quality of life of patients living with chronic diseases. PV: Wh...

    By Karin Kleinhaus • Sept. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Gene Therapy: Delivering on the Promise

    It’s been 16 years since tragedy struck in the clinical research world. A patient in an experimental gene therapy trial died just days after receiving the therapy. In 1999, Jesse Gelsinger came to the University of Pennsylvania with a rare metabolic disorder that prevents the body from breaking d...

    By Denise Myshko • Sept. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    C-Suite: Clinical Service

    Contract Research Organizations C-Suite executives from some of the industry’s leading CROs provide their insights on where the greatest opportunities lie for improving clinical research operations, the greatest challenges involved with the trial process, and best practices to enhance clinical op...

    By Taren Grom • Sept. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    Celebrating Inspiration When we first conceptualized this special issue 11 years ago, the idea was that it would be nice to showcase the people who are having a positive impact on the industry. We didn’t know then that this issue would come to mean so much more than a metaphoric high five. Over t...

    By Taren Grom • Aug. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Who's on the list by Company

    AbelsonTaylor Inc.    Keith Stenlund Achillion Pharmaceuticals    Kevin Kucharski Advanced Clinical LLC    Leo Sheridan Alcobra Pharma    David Baker Altasciences    Chris Perkin AmerisourceBergen Corp.    Marc Kikuchi Artcraft Health    Marc Sirockman Astellas Pharma US Inc.    Jim Robinson Astr...

    By PharmaVoice Team • Aug. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Tools of the Trade

    TGaS Advisors Launches Emerging Life Sciences Network  Trending Now: The network provides peer support, data, and insights for accelerating commercial success. TGaS Advisors, a benchmarking and advisory services firm for life-sciences commercial organizations, has launched the Emerging Life Scien...

    By PharmaVoice Team • Aug. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Pharma Pool Marcello Agosti Takeda Names Head of New Global Commercial Organization Takeda has named Marcello Agosti head of global commercial, based in Zurich. The company established the global commercial organization as part of its plans to structure operations to become more agile and custome...

    By PharmaVoice Team • Aug. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Who's On The List by Section

    Commanders & Chiefs Dr. Michelle Berrey    Chimerix Rob Cosinuke    athenahealth and Epocrates Jim Curtis    Remedy Health Media Dr. Bruce Feinberg    Cardinal Health Specialty Solutions Lisa Giles    Giles & Associates Consultancy Inc. and Optivara Inc. Peter Goldschmidt    Sandoz Inc. D...

    By PharmaVoice Team • Aug. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Researchers & Scientists

    Dr. Anish Suri Title: Senior Scientific Director, Discovery Immunology Company: Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson Education: Ph.D., Immunology, Washington University St. Louis; B.S., Biology, Angelo State University Famil...

    By PharmaVoice Team • Aug. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Fun Facts About the PharmaVOICE 100

    Where they were born? The PharmaVOICE 100 may come from all over, but what they have in common is a sincere desire to improve the lives of patients everywhere. What was their first job? We thought it would be fun to know how these highly successful executives earned their first paychecks. As it t...

    By PharmaVoice Team • Aug. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Overcoming the Challenges that Hinder Innovation

    PharmaVOICE 100 honorees discuss the challenges that the industry needs to overcome to support future innovation. Between 2009 and 2014, the annual growth rate for the top 25 life-sciences companies slowed from the prior decade’s double-digit average to only 1% annually, according to a recent rep...

    By PharmaVoice Team • Aug. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Innovation In a Patient-Centric World

    From healthcare reform to the push for value in medicines to personalized healthcare, the patient is now at the center of, well, everything. This means that pharmaceutical companies are now required to create a new paradigm, with the patient at the center. An initiative that began last year withi...

    By PharmaVoice Team • Aug. 1, 2015